{"id":"https://openalex.org/A5060308277","orcid":"https://orcid.org/0009-0005-7279-0106","observed_orcids":["https://orcid.org/0009-0005-7279-0106"],"display_name":"Charlie Cruze","raw_author_names":["Charlie Cruze"],"full_name":"Charlie Cruze","works_count":13,"cited_by_count":8,"summary_stats":{"2yr_mean_citedness":0.6363636363636364,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5060308277","orcid":"https://orcid.org/0009-0005-7279-0106","observed_orcids":["https://orcid.org/0009-0005-7279-0106"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210144148","ror":"https://ror.org/047kvxr97","display_name":"Bexion Pharmaceuticals (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210144148"]},"years":[2024,2023]}],"last_known_institutions":[{"id":"https://openalex.org/I4210144148","ror":"https://ror.org/047kvxr97","display_name":"Bexion Pharmaceuticals (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210144148"]}],"topics":[{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","count":12,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","count":12,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","count":11,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","count":1,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","value":0.0001343,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","value":9.54e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","value":7.83e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","value":1.74e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","value":8.9e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.8283306360244751},{"id":"61705674","wikidata":"https://www.wikidata.org/wiki/Q410395","display_name":"Sphingolipid","score":0.6890036463737488},{"id":"502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","score":0.6633442640304565},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.5773138403892517},{"id":"143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","score":0.43481236696243286}],"counts_by_year":[{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":1},{"year":2023,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2024,"works_count":11,"oa_works_count":10,"cited_by_count":2},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":3},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":2}],"display_name_alternatives":["Charlie Cruze"],"block_key":"c cruze","works_api_url":"https://api.openalex.org/works?filter=author.id:A5060308277","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5060308277","updated_date":"2026-11-12T13:17:38","created_date":"2023-04-06T00:00:00"}